GLIMZAB MV 1mg is a fixed dose combination medication that contains Voglibose (0.30mg/Tablet), Metformin (500.00mg/Tablet), and Glimepiride (1.00mg/Tablet). Voglibose is an alpha-glucosidase inhibitor that helps control blood sugar levels by delaying the digestion and absorption of carbohydrates. Metformin is a biguanide that improves insulin sensitivity and reduces glucose production in the liver. Glimepiride is a sulfonylurea that stimulates insulin secretion from the pancreas. This combination is used to manage type 2 diabetes mellitus when diet and exercise alone are not sufficient. It helps lower blood sugar levels and improve glycemic control.  

• Management of type 2 diabetes mellitus

• Diarrhea
• Nausea
• Hypoglycemia
• Abdominal pain
• Skin rash

Take GLIMZAB MV 1mg orally with meals, as directed by your doctor. The dosage and frequency of administration will depend on your individual medical condition. Follow your doctor's instructions carefully.

• Pregnancy - GLIMZAB MV 1mg is not recommended for use during pregnancy. Consult your doctor for safer alternatives.
• Alcohol - It is advisable to avoid alcohol while taking GLIMZAB MV 1mg as it may increase the risk of lactic acidosis.
• Old Age - Caution is advised while using GLIMZAB MV 1mg in elderly patients, as they may be more prone to the side effects of this medication. Your doctor may need to adjust the dosage accordingly.
• Breast Feeding - GLIMZAB MV 1mg is not recommended for use while breastfeeding. Consult your doctor for safer alternatives.
• Children - GLIMZAB MV 1mg is not recommended for use in children. Consult your doctor for safer alternatives.

• Store at room temperature (20-25°C) -
• Protect from moisture and light -

• Drug-Drug - This medication may interact with other antidiabetic drugs, beta-blockers, corticosteroids, diuretics, and certain medications metabolized by the liver or kidneys. Inform your doctor about all the medicines you are taking.
• Drug-Food - There are no known significant drug-food interactions with GLIMZAB MV 1mg.
• Drug-Disease - GLIMZAB MV 1mg should be used with caution in patients with liver or kidney disease, heart diseases, or a history of lactic acidosis. Your doctor may need to adjust the dosage accordingly.

• Q. Can I skip a dose if my blood sugar is under control?
  No, it is important to take GLIMZAB MV 1mg as prescribed by your doctor even if your blood sugar is under control. Skipping doses may lead to loss of glycemic control.
• Q. What should I do if I experience symptoms of hypoglycemia?
  If you experience symptoms of hypoglycemia such as dizziness, tremors, sweating, or confusion, you should immediately consume a source of fast-acting glucose, such as glucose tablets or a sugary beverage. Contact your doctor for further instructions.
• Q. Can GLIMZAB MV 1mg cause weight gain?
  Glimepiride, one of the components of GLIMZAB MV 1mg, may cause weight gain in some individuals. However, the effect may vary from person to person.
• Q. Can GLIMZAB MV 1mg be used in type 1 diabetes?
  No, GLIMZAB MV 1mg is not recommended for use in type 1 diabetes. It is specifically indicated for management of type 2 diabetes mellitus.
• Q. Can I stop taking GLIMZAB MV 1mg if my blood sugar levels are well-controlled?
  It is important to continue taking GLIMZAB MV 1mg as prescribed by your doctor, even if your blood sugar levels are well-controlled. Stopping the medication without medical guidance may lead to a recurrence of high blood sugar levels.